5,6,7,8-Tetrahydro-3-(5-methoxy-1,3,4-oxadiazol-2-yl)-6-(phenylmethyl)-1,6-naphthyridin-2(1H)-one

CAS: 156364-04-4

Ref. 3D-GGA36404

Produktinformation

• Name: 5,6,7,8-Tetrahydro-3-(5-methoxy-1,3,4-oxadiazol-2-yl)-6-(phenylmethyl)-1,6-naphthyridin-2(1H)-one
• Marke: Biosynth
• Beschreibung: 5,6,7,8-Tetrahydro-3-(5-methoxy-1,3,4-oxadiazol-2-yl)-6-(phenylmethyl)-1,6-naphthyridin-2(1H)-one is a new chemical entity that binds to the human receptor for advanced glycation end products (RAGE) and blocks the activation of this receptor. It has been shown to inhibit the activity of ion channels, like the nicotinic acetylcholine receptor and the voltage gated potassium channel. 5,6,7,8-Tetrahydro-3-(5-methoxy-1,3,4-oxadiazol-2-yl)-6-(phenylmethyl)-1,6 -naphthyridin-2(1H)-one has been shown to be a potent inhibitor of protein synthesis in cell culture. It is also a high purity

Chemische Eigenschaften

• Molekulargewicht: 338.4 g/mol
• Formel: C₁₈H₁₈N₄O₃
• Reinheit: Min. 95%